Eli Lilly-Backed Scribe Therapeutics Soars 44% After IPO.

Saved in:
Bibliographic Details
Title: Eli Lilly-Backed Scribe Therapeutics Soars 44% After IPO.
Authors: Adegbesan, Angel (AUTHOR)
Source: Bloomberg.com. 7/24/2026, pN.PAG-N.PAG. 1p.
Database: Business Source Ultimate
Full text is not displayed to guests.
Description
Description not available.